Limitations of randomized clinical trials to recognize possible advantages of combination therapies in rheumatic diseases
- 1 October 1993
- journal article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 23 (2) , 2-10
- https://doi.org/10.1016/s0049-0172(10)80002-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Rheumatoid arthritis: Disappointing long-term outcomes despite successful short-term clinical trialsJournal of Clinical Epidemiology, 1988
- An Additional Basic Science for Clinical Medicine: II. The Limitations of Randomized TrialsAnnals of Internal Medicine, 1983
- Prednisone and azathioprine for polymyositis. Long‐term followupArthritis & Rheumatism, 1981
- Azathioprine with Prednisone for PolymyositisAnnals of Internal Medicine, 1980
- Azathioprine plus Prednisone Compared with Prednisone Alone in the Treatment of Systemic Lupus ErythematosusAnnals of Internal Medicine, 1975
- Further observations on the treatment of lupus nephritis with prednisone and combined prednisone and azathioprineArthritis & Rheumatism, 1974
- Comparison of Azathioprine, Prednisone, and Heparin Alone or Combined in Treating Lupus nephritisNephron, 1973
- The Randomized Clinical TrialNew England Journal of Medicine, 1972
- Controlled Studies in Clinical Cancer ResearchNew England Journal of Medicine, 1972
- Azathioprine in the treatment of systemic lupus erythematosus. A controlled studyArthritis & Rheumatism, 1971